Warning letter
Wedgewood Village Pharmacy, Inc.: warning letter of Feb 21, 2014
FDA warning letter 395218 · New Jersey District Office
Key facts
| Reference number | 395218 |
|---|---|
| Company | Wedgewood Village Pharmacy, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Feb 21, 2014 |
| Posted date | Mar 4, 2014 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| CFR sections cited | 211.198(a), 201.115, 211.42(d), 211 |
| Inspection city | Swedesboro |
| Inspection ZIP | 08085 |
| Inspection start date | Nov 9, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: